Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDecreaseIncreaseInInventories

Value{"amount": 866573, "currency": "USD"}
Period2022-01-01 – 2022-12-31
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/6b9f9c73-5ac8-470d-b6c7-9be1a9050dfb

History